CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 90 filers reported holding CYTOSORBENTS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,535,980 | -44.8% | 2,944,670 | +5.4% | 0.84% | -41.8% |
| Q2 2023 | $10,028,557 | +8.0% | 2,793,470 | +1.4% | 1.44% | +6.0% |
| Q1 2023 | $9,284,249 | +135.6% | 2,754,970 | +8.4% | 1.36% | +117.6% |
| Q4 2022 | $3,940,241 | +23.4% | 2,542,091 | +8.3% | 0.62% | +19.1% |
| Q3 2022 | $3,192,000 | -37.3% | 2,347,034 | +0.9% | 0.52% | -29.9% |
| Q2 2022 | $5,092,000 | -25.0% | 2,324,997 | +9.3% | 0.75% | -9.1% |
| Q1 2022 | $6,788,000 | -16.8% | 2,127,952 | +9.3% | 0.82% | -12.7% |
| Q4 2021 | $8,155,000 | -45.3% | 1,946,374 | +5.9% | 0.94% | -48.9% |
| Q3 2021 | $14,921,000 | +11.5% | 1,837,541 | +3.7% | 1.84% | +16.3% |
| Q2 2021 | $13,379,000 | -2.3% | 1,772,000 | +12.4% | 1.58% | -9.1% |
| Q1 2021 | $13,690,000 | +12.5% | 1,577,200 | +3.3% | 1.74% | -1.2% |
| Q4 2020 | $12,173,000 | +7.3% | 1,527,400 | +7.4% | 1.76% | -6.7% |
| Q3 2020 | $11,345,000 | -3.9% | 1,421,700 | +19.2% | 1.89% | -9.3% |
| Q2 2020 | $11,809,000 | +35.6% | 1,192,800 | +5.9% | 2.09% | +8.1% |
| Q1 2020 | $8,706,000 | +177.2% | 1,126,300 | +38.0% | 1.93% | +323.5% |
| Q4 2019 | $3,141,000 | -19.3% | 815,869 | +5.4% | 0.46% | -19.4% |
| Q3 2019 | $3,894,000 | -13.4% | 774,250 | +13.8% | 0.57% | -8.6% |
| Q2 2019 | $4,499,000 | -6.6% | 680,600 | +7.0% | 0.62% | -7.1% |
| Q1 2019 | $4,815,000 | +20.2% | 636,050 | +28.3% | 0.67% | +1.4% |
| Q4 2018 | $4,006,000 | -32.2% | 495,850 | +8.3% | 0.66% | -13.9% |
| Q3 2018 | $5,909,000 | +4.4% | 458,050 | -7.8% | 0.76% | +2.4% |
| Q2 2018 | $5,661,000 | +16.9% | 496,550 | -27.7% | 0.74% | +16.8% |
| Q1 2018 | $4,843,000 | +2.7% | 686,950 | -5.3% | 0.64% | +4.9% |
| Q4 2017 | $4,716,000 | +52.1% | 725,608 | +45.1% | 0.61% | +47.6% |
| Q3 2017 | $3,100,000 | +21.3% | 500,050 | -15.9% | 0.41% | +16.7% |
| Q2 2017 | $2,555,000 | +79.3% | 594,250 | +87.7% | 0.35% | +80.1% |
| Q1 2017 | $1,425,000 | +1040.0% | 316,600 | +1276.5% | 0.20% | +931.6% |
| Q4 2016 | $125,000 | -15.0% | 23,000 | 0.0% | 0.02% | -17.4% |
| Q3 2016 | $147,000 | -33.2% | 23,000 | -52.4% | 0.02% | -36.1% |
| Q2 2016 | $220,000 | +6.8% | 48,350 | -7.9% | 0.04% | +9.1% |
| Q1 2016 | $206,000 | -29.5% | 52,500 | 0.0% | 0.03% | -21.4% |
| Q4 2015 | $292,000 | -11.8% | 52,500 | 0.0% | 0.04% | -6.7% |
| Q3 2015 | $331,000 | – | 52,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 450,000 | $846,000 | 0.90% |
| Skylands Capital, LLC | 2,944,670 | $5,535,980 | 0.84% |
| Sargent Investment Group, LLC | 1,257,048 | $2,363,250 | 0.57% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 197,940 | $372,127 | 0.52% |
| Avenir Corp | 2,717,397 | $5,108,706 | 0.48% |
| Granahan Investment Management | 1,552,393 | $2,918,499 | 0.10% |
| Seelaus Asset Management LLC | 20,450 | $38,446 | 0.04% |
| HighMark Wealth Management LLC | 10,000 | $18,800 | 0.02% |
| Key Client Fiduciary Advisors, LLC | 13,000 | $24,440 | 0.02% |
| Eudaimonia Partners, LLC | 23,500 | $44,180 | 0.01% |